Medical imaging software and devices company Exo has appointed Kurt Hammond as its chief commercial officer.
Hammond will be responsible for developing and executing the sales, marketing, and partnerships to support the commercialization of Exo's integrated ultrasound ecosystem.
Hammond most recently served as chief growth officer at eMed Digital Healthcare. Prior to that, he led six healthcare startups, including Halo Health and Merge Healthcare, and has been involved in more than 20 mergers and acquisitions in the healthcare market. After Merge Healthcare was acquired by IBM in 2015, Hammond was named vice president of global imaging sales for IBM Watson Health, and he was eventually promoted to global vice president of partnerships and business development.
